Structure's GLP-1 Pill Could Be Big, But Trial Results Will Confirm Shares of Structure Therapeutics (NASDAQ: GPCR) have far outperformed both of the companies above in the last year, rising by over 150% during that time as investors have grown enthusiastic about aleniglipron, the firm's GLP-1 agonist candidate
The typical monthly cost for compounded GLP-1 therapy through a reputable telehealth provider ranges from $150 to $400 per month , depending on the specific medication, dosage tier, and whether the provider bundles consultations into the price
However, costs vary based on dosage and subscription plans, and insurance coverage is often limited
Wegovy is FDA-approved for adolescents 12 and older
Patients who have achieved 10-15% weight loss, normalized key biomarkers, and developed sustainable dietary and exercise habits may be candidates for a maintenance phaselower doses, spacing doses further apart, or transitioning to oral formulations